title: End-stage liver disease and liver transplant: current situation and key issues.
authors.affiliation: Université Catholique de Louvain, Cliniques St Luc, Brussels, Belgium. etienne.sokal@uclouvain.be
authors.forename: E M
authors.initials: EM
authors.lastname: Sokal
authors.forename: D
authors.initials: D
authors.lastname: Goldstein
authors.forename: M
authors.initials: M
authors.lastname: Ciocca
authors.forename: P
authors.initials: P
authors.lastname: Lewindon
authors.forename: Y H
authors.initials: YH
authors.lastname: Ni
authors.forename: T
authors.initials: T
authors.lastname: Silveira
authors.forename: A
authors.initials: A
authors.lastname: Sibal
authors.forename: A
authors.initials: A
authors.lastname: Dhawan
authors.forename: C
authors.initials: C
authors.lastname: Mack
authors.forename: J
authors.initials: J
authors.lastname: Bucuvalas
mesh_terms: D002648:Child; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D017093:Liver Failure / Q000601:surgery / Q000628:therapy*; D016031:Liver Transplantation; D018579:Patient Selection; D011183:Postoperative Complications / Q000453:epidemiology* / Q000517:prevention & control; D033581:Stem Cell Transplantation / Q000379:methods*
chemical_list: D007166:Immunosuppressive Agents